ストックスクリーナーアプリを入手
3.32
2.35%
-0.08
アフターアワーズ：
3.30
-0.02
-0.60%
前日終値:
$3.40
開ける：
$3.38
24時間の取引高:
144.74K
Relative Volume:
1.06
時価総額：
$39.72M
収益：
$12,000
当期純損益:
$-48.41M
株価収益率:
-0.1932
EPS:
-17.181
ネットキャッシュフロー:
$-19.99M
1週間 パフォーマンス:
-8.79%
1か月 パフォーマンス:
-11.47%
6か月 パフォーマンス:
+3.11%
1年 パフォーマンス:
-81.40%
1日の値動き範囲:
$3.26
$3.38
1週間の範囲:
$3.26
$3.72
52週間の値動き範囲:
$2.49
$19.71
Incannex Healthcare Inc Stock (IXHL) Company Profile
名前
Incannex Healthcare Inc
セクター
電話
61 409 840 786
住所
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL vs TAK, TEVA, HLN, ZTS, VTRS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
3.32 | 39.72M | 12,000 | -48.41M | -19.99M | -17.18 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Incannex Healthcare Inc (IXHL) 最新ニュース
Incannex Healthcare | 10-K: Annual report - Moomoo
Incannex Healthcare Inc. FY 2026: Revenue $0 Net income ($19.3M), EPS ($1.66) — 10-K Summary - TradingView
Incannex Healthcare Inc expected to post a loss of 75 cents a shareEarnings Preview - TradingView
Why Did Incannex (NASDAQ:IXHL) Dose Its First Sleep-Apnea Patient? - Kalkine Media
Incannex begins Phase 2 dosing study for sleep apnea drug By Investing.com - Investing.com South Africa
$Incannex Healthcare (IXHL.US)$ - Moomoo
Incannex Begins Dosing in Phase 2 Sleep Apnea Trial - minichart.com.sg
Incannex begins Phase 2 dosing study for sleep apnea drug - Investing.com
A company with about $70 million in cash and no debt is testing a sleep-apnea treatment. - Stock Titan
IXHLIncannex Healthcare Inc Revenue Breakdown - Finviz
BB: BlackBerry Ltd Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Why Did IXHL Stock Tank Over 32% Today? - Stocktwits
Enterprise value to EBIT forward of Incannex Healthcare Limited – LSX:A2DF4D - TradingView
IXHL Should I Buy - intellectia.ai
IXHL Q4'26 Earnings: EPS estimate is (0.14) USD - TradingView
Incannex Healthcare (IXHL) Slides 4.97% to $3.46, Testing Support at $3.29ETF Premium Discount - vinanet.vn
What’s Next for Incannex Healthcare (ASX:IHL) After US Patent Win? - Kalkine Media
IXHL Q4'26 Earnings: revenue estimate is 0 USD - TradingView
Incannex doses first patient in sleep apnea drug trial By Investing.com - Investing.com Nigeria
Incannex doses first patient in sleep apnea drug trial - Investing.com India
Incannex (IXHL) Advances Sleep Apnea Drug Trial Amid High Price-to-Sales Valuation - GuruFocus
Incannex Healthcare Doses First Patient in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea - Quiver Quantitative
Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X - Barchart.com
IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms - Stocktwits
Incannex Healthcare (ASX:IHL) Cash Flow Check: What Investors Need to Watch on 19 August - Kalkine Media
Why Is Incannex Healthcare (ASX:IHL) in Market Focus? - Kalkine Media
Incannex Wins US Patent Lift For Sleep Apnoea Pipeline (ASX:IHL) - Kalkine Media
Incannex Healthcare (IXHL) Shows Modest Uptick, Holding Key Support Amid Clinical Pipeline FocusTrend Continuation Trade - vinanet.vn
Incannex Healthcare (IXHL) Climbs 3.8% to $3.28, Testing Key Resistance ZoneMcClellan Summation - vinanet.vn
Polar Asset Management (IXHL) reports 7.0% beneficial stake via 900,000 warrants - Stock Titan
Incannex (ASX:IHL): What Is Changing in the Liquidity Test? - Kalkine Media
Why Does Incannex Healthcare (ASX:IHL) Shape Discipline? - Kalkine Media
Incannex Healthcare (ASX:IHL) Clinical Development Pipeline: Market Outlook - Kalkine Media
Incannex Healthcare Inc. (IXHL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incannex Healthcare Inc. (IXHL) options chain - Yahoo Finance Singapore
Incannex Secures A$5.1M R&D Tax Incentive Refund - theglobeandmail.com
Why Are Incannex Healthcare (ASX:IHL), Cann Group (ASX:CAN), ECS Botanics (ASX:ECS) and Little Green Pharma (ASX:LGP) Back in the Market Spotlight? - Kalkine Media
Why Are BrainChip (ASX:BRN), Incannex Healthcare (ASX:IHL), Lake Resources (ASX:LKE) and Cann Group (ASX:CAN) Back in the Market Spotlight? - Kalkine Media
Incannex receives final A$5.1m R&D tax incentive refund By Investing.com - Investing.com UK
Incannex Healthcare Inc. (IXHL) stock price, news, quote and history - Yahoo Finance Singapore
Incannex receives final A$5.1m R&D tax incentive refund - Investing.com
Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 - The Manila Times
Form 8K Incannex Healthcare Inc. For: 11 August By Investing.com - Investing.com Nigeria
Press Release: Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 - Moomoo
Incannex receives A$5.1M final R&D refund, totaling A$11.2M non-dilutive funding - TradingView
IXHL Forecast & Price Target - TradingKey
Can Incannex (ASX:IHL) Reshape The Cannabis Conversation? - Kalkine Media
Incannex Healthcare Inc (IXHL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Incannex Healthcare Inc. (IXHL) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Incannex Healthcare Inc (IXHL) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Incannex Healthcare Inc (IXHL) 財務データ
収益
当期純利益
現金流量
EPS
0.18%
0.69%
大文字化:
|
ボリューム (24 時間):